MUCINEX Trademark
Trademark Overview
On Monday, April 15, 2024, a trademark application was filed for MUCINEX with the United States Patent and Trademark Office. The USPTO has given the MUCINEX trademark a serial number of 98499792. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 19, 2024. This trademark is owned by RB Health (US) LLC. The MUCINEX trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; preparations for the treatment of respiratory and pulmonary conditions; expectorants; anti-pyretic preparations, namely, pharmaceutical preparations for reducing fever; decongestants; cough suppressant; pharmaceutical antitussive-cold preparations; preparations for treating colds
General Information
| Serial Number | 98499792 |
| Word Mark | MUCINEX |
| Filing Date | Monday, April 15, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, November 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 19, 2024 |
Trademark Statements
| Description of Mark | The mark consists of the word "MUCINEX" imprinted on a three-dimensional product configuration of pink and white bi-layer tablet. The dashed lines depicting the oblong dosage tablet indicate placement of the mark on the goods and that the shape of the product is not claimed as part of the mark, and the dashed lines are not part of the mark. |
| Goods and Services | Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; preparations for the treatment of respiratory and pulmonary conditions; expectorants; anti-pyretic preparations, namely, pharmaceutical preparations for reducing fever; decongestants; cough suppressant; pharmaceutical antitussive-cold preparations; preparations for treating colds |
| Indication of Colors claimed | The color(s) Pink and white is/are claimed as a feature of the mark. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 15, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | RB Health (US) LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Parsippany, NJ 07054 |
| Party Name | RB Health (US) LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Parsippany, NJ 07054 |
Trademark Events
| Event Date | Event Description |
| Monday, April 15, 2024 | NEW APPLICATION ENTERED |
| Monday, August 26, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, August 26, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, October 4, 2024 | ASSIGNED TO EXAMINER |
| Monday, October 7, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 13, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 19, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 19, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
